Search hospitals > New York > Brooklyn
New York Methodist Hospital
Claim this profileBrooklyn, New York 11215
Global Leader in Breast Cancer
Global Leader in Prostate Cancer
Conducts research for Lung Cancer
Conducts research for Heart Failure
Conducts research for Brain Tumor
218 reported clinical trials
14 medical researchers
Summary
New York Methodist Hospital is a medical facility located in Brooklyn, New York. This center is recognized for care of Breast Cancer, Prostate Cancer, Lung Cancer, Heart Failure, Brain Tumor and other specialties. New York Methodist Hospital is involved with conducting 218 clinical trials across 355 conditions. There are 14 research doctors associated with this hospital, such as Hani Ashamalla, M.D., Scott Tagawa, MD, Uqba Khan, and Margaux J. Kanis.Area of expertise
1Breast Cancer
Global LeaderHER2 negative
ER positive
HER2 positive
2Prostate Cancer
Global LeaderStage IV
Top PIs
Hani Ashamalla, M.D.New York-Presbyterian/Brooklyn Methodist Hospital3 years of reported clinical research
Studies Breast Cancer
Studies Brain Tumor
19 reported clinical trials
48 drugs studied
Scott Tagawa, MDWeill Cornell Medical College4 years of reported clinical research
Expert in Prostate Cancer
Studies Renal Cell Carcinoma
14 reported clinical trials
32 drugs studied
Uqba KhanNew York-Presbyterian/Brooklyn Methodist Hospital2 years of reported clinical research
Studies Colorectal Cancer
Studies Colon Cancer
5 reported clinical trials
17 drugs studied
Margaux J. KanisNew York-Presbyterian/Brooklyn Methodist Hospital6 years of reported clinical research
Studies Fallopian Tube Carcinosarcoma
Studies Endometrial Adenocarcinoma
3 reported clinical trials
7 drugs studied
Clinical Trials running at New York Methodist Hospital
Breast Cancer
Bladder Cancer
Bladder Carcinoma
Heart Failure
Prostate Cancer
Lung Cancer
Kidney Cancer
Esophageal cancer
Coronary Artery Disease
Brain Tumor
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Omitting Radiation Therapy
for Breast Cancer
The purpose of this study is to compare the effects on low risk breast cancer receiving usual care that includes regional radiation therapy, with receiving no regional radiation therapy. Researchers want to see if not giving this type of radiation treatment works as well at preventing breast cancer from coming back.
Recruiting2 awards Phase 319 criteria
Low Dose Tamoxifen
for Breast Cancer
This phase III trial compares the effect of low dose tamoxifen to usual hormonal therapy, including aromatase inhibitors, in treating post-menopausal women with hormone positive, HER2 negative early stage breast cancer. Tamoxifen is in a class of medications known as antiestrogens. It blocks the activity of estrogen (a female hormone) in the breast. This may stop the growth of some breast tumors that need estrogen to grow. Aromatase inhibitors, such as anastrozole, letrozole, and exemestane, prevent the formation of estradiol, a female hormone, by interfering with an aromatase enzyme. Aromatase inhibitors are used as a type of hormone therapy to treat postmenopausal women with hormone-dependent breast cancer. Giving low dose tamoxifen may be more effective compared to usual hormone therapy in treating post-menopausal women with hormone-positive, HER2 negative early stage breast cancer.
Recruiting2 awards Phase 38 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at New York Methodist Hospital?
New York Methodist Hospital is a medical facility located in Brooklyn, New York. This center is recognized for care of Breast Cancer, Prostate Cancer, Lung Cancer, Heart Failure, Brain Tumor and other specialties. New York Methodist Hospital is involved with conducting 218 clinical trials across 355 conditions. There are 14 research doctors associated with this hospital, such as Hani Ashamalla, M.D., Scott Tagawa, MD, Uqba Khan, and Margaux J. Kanis.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.